Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.9%

4 terminated out of 138 trials

Success Rate

92.5%

+5.9% vs benchmark

Late-Stage Pipeline

10%

14 trials in Phase 3/4

Results Transparency

10%

5 of 49 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

69Total
Not Applicable (44)
P 1 (4)
P 2 (7)
P 3 (3)
P 4 (11)

Trial Status

Completed49
Unknown39
Recruiting26
Not Yet Recruiting10
Active Not Recruiting6
Terminated4

Trial Success Rate

92.5%

Benchmark: 86.6%

Based on 49 completed trials

Clinical Trials (138)

Showing 20 of 20 trials
NCT05532540Active Not Recruiting

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study

NCT05700799Not ApplicableCompletedPrimary

HEalth Advocate for Liver Transplant - Pilot

NCT06386198Not ApplicableRecruitingPrimary

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

NCT07715500Not ApplicableRecruiting

Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications

NCT06905054Phase 2Recruiting

Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

NCT05260268Not ApplicableActive Not RecruitingPrimary

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

NCT05818644Completed

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

NCT04592744Phase 4Active Not Recruiting

Angiotensin 2 for AKI After OLT

NCT07305363Phase 2Not Yet RecruitingPrimary

Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC).

NCT06257407RecruitingPrimary

Perioperative Hemostasis Management in Liver Transplantation

NCT04901169Phase 2Active Not RecruitingPrimary

Angiotensin II in Liver Transplantation

NCT05042505Not ApplicableCompleted

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

NCT06879106Not ApplicableCompletedPrimary

Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation

NCT07409532CompletedPrimary

Intraoperative Assessment of Renal Tissue Oxygenation Using NIRS

NCT07362745Completed

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

NCT05241847Not ApplicableCompletedPrimary

Starzl Network Patient Reported Outcomes

NCT06169592Recruiting

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

NCT06958796Phase 4Recruiting

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

NCT07169643Phase 3RecruitingPrimary

Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)

NCT06816628Not ApplicableCompletedPrimary

Effects of Comedy Therapy on Pain and Comfort Levels in Liver Transplant Recipients

Scroll to load more

Research Network

Activity Timeline